Peptide mixtures were separated using a gradient from 92% A (0.1% formic acid in water) and 8% B (0.1% formic acid in acetonitrile) to 33% B, in 44?min at 300?nl/min, using a 75?mm250?m internal diameter 1.7?M BEH C18 analytical column (Waters). specific Arp2/3-binding deficient mutant that the SharpinCArp2/3 interaction promotes lamellipodium formation in a LUBAC-independent fashion. This article has an associated First Person interview with the first author of the paper. pulldown assay, showing that recombinant GSTCSharpin (Fig.?S2F; Rantala et al., 2011), but not GST alone, was able to pull down a purified bovine Arp2/3 complex (Fig.?2F). Therefore, we conclude that Sharpin and the Arp2/3 complex interact directly. Open in a separate window Fig. 2. Sharpin and the Arp2/3 complex CHMFL-ABL-039 interact in cells. (A) PLA with indicated antibody pairs in HeLa cells (rb-GFP and mo-GFP represent mouse and rabbit antibodies against GFP). DAPI indicates nuclei. The graph shows average number of PLA signals (spots) per cell ((chronic proliferative dermatitis)] mice (Rantala et al., CHMFL-ABL-039 2011). Under these conditions, overexpression of GFPCSharpin WT increased cell migration compared to that seen upon overexpression of GFP alone (Fig.?6). Importantly, MEFs overexpressing CNOT4 GFPCSharpin V240A/L242A, which is unable to bind the Arp2/3 complex (Fig.?3C,D) and support lamellipodium formation (Fig.?5) but is fully capable of inhibiting integrins (De Franceschi et al., 2015), did not migrate significantly faster than those overexpressing GFP alone (Fig.?6). On the other hand, GFPCSharpin V240A/L242A-overexpressing MEFs did migrate slower than their counterparts overexpressing GFPCSharpin WT, CHMFL-ABL-039 suggesting that, under these conditions, Sharpin promotes cell migration through interaction with the Arp2/3 complex, rather than through integrin inhibition. Open in a separate window Fig. 6. Sharpin promotes cell migration through interaction with the Arp2/3 complex. (A) Quantification of migration speed and (B) representative cell tracks (4.5?h) of MEFs overexpressing GFP alone, WT GFPCSharpin or GFPCSharpin V240A/L242A on 5?g/ml fibronectin [(Fig.?2G). However, we cannot rule out that post-translational modifications of Sharpin or other proteins that have yet to be identified could mediate the SharpinCArp2/3 interplay in cells. For example, lamellipodium formation CHMFL-ABL-039 could be regulated by a multiprotein interaction, such as a SharpinCintegrinCArp2/3 complex. Alternatively, the SharpinCArp2/3 interaction could enhance signalling to the Arp2/3 complex or modulate the Arp2/3Ccortactin interaction, consistent with the role for Sharpin in formation of signal-induced lamellipodia (Fig.?4C; Fig.?S5B,C). Sharpin does not regulate cortactin stability, however, as cortactin levels are largely unaffected in the absence of Sharpin (Fig.?S2E,I) One potential mechanism through which Sharpin could promote lamellipodium formation is stabilisation of the active Arp2/3 conformation, which is consistent with our observations that Arp2/3 levels are modestly reduced upon Sharpin silencing or knockout (Fig.?S2E,H,I) and that the SharpinCArp2/3 interaction depends on Arp2/3 activity (Fig.?S3A,C). Reduced Arp2/3 levels are unlikely to completely explain the Sharpin phenotype, however, as reducing Arp3 levels by 60% using siRNA in NCI-H460 cells (Fig.?S2H) reduced lamellipodium formation by 50% (Fig.?4A), while lamellipodium formation in Sharpin KO1 NCI-H460 cells, which show modestly reduced Arp2 levels (2410%, means.e.m.; Fig. S2I), is reduced by 75% (Fig.?4B). Lamellipodia induced by constitutively active RAC [GFPCRAC(Q61L)] were not affected by the absence of Sharpin (Fig.?S6A,B), which could CHMFL-ABL-039 suggest that Sharpin regulates lamellipodium formation upstream of RAC. However, GFPCRAC(Q61L)-induced lamellipodia in NCI-H460 cells were fully resistant to 6?h Arp2/3 inhibition with CK666 (data not shown), suggesting that GFPCRAC(Q61L)-induced lamellipodia are hyperstable. Therefore, while lamellipodia formation is strongly reduced in the absence of Sharpin (Figs?4 and ?and5;5; Fig.?S5), such lamellipodia could become.
Categories:Shp2